News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Chen Bihua
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Bought 58,839 shares
@ $59.8973, valued at
$3.5M
|
|
| 10/04/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Bought 74,911 shares
@ $57.37, valued at
$4.3M
Bought 150,487 shares
@ $57.252, valued at
$8.6M
Bought 67,814 shares
@ $57.3188, valued at
$3.9M
|
|
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Bought 800,000 shares
@ $50, valued at
$40M
|
|
| 06/28/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Bought 1,481 shares
@ $36.91, valued at
$54.7k
Bought 3,755 shares
@ $38.18, valued at
$143.4k
Bought 10,593 shares
@ $39.17, valued at
$414.9k
Bought 38,623 shares
@ $39.87, valued at
$1.5M
Bought 50,642 shares
@ $41.03, valued at
$2.1M
Bought 61,042 shares
@ $42.12, valued at
$2.6M
Bought 66,087 shares
@ $43.3, valued at
$2.9M
Bought 31,558 shares
@ $44.23, valued at
$1.4M
Bought 10,946 shares
@ $44.93, valued at
$491.8k
Bought 37,783 shares
@ $48.93, valued at
$1.8M
Bought 59,787 shares
@ $49.82, valued at
$3M
|
|
| 06/16/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 6,989 options to buy
@ $38.9, valued at
$271.9k
|
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Bought 400,000 shares
@ $30, valued at
$12M
|
|
| 03/22/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Bought 446,881 shares
@ $19.3639, valued at
$8.7M
Bought 63,700 shares
@ $20.4207, valued at
$1.3M
Bought 78,008 shares
@ $21.0836, valued at
$1.6M
Bought 238,511 shares
@ $21.7013, valued at
$5.2M
|
|
| 03/16/2023 |
4
| Cormorant Asset Management, LP (10% Owner) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Bought 250,000 shares
@ $9.9531, valued at
$2.5M
Bought 250,000 shares
@ $10.5955, valued at
$2.6M
Bought 500,000 shares
@ $10.1485, valued at
$5.1M
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2022 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Converted 2,785,000 shares
@ $0
Bought 2,850,000 shares
@ $10, valued at
$28.5M
Converted 2,785,000 options to buy
@ $0 |
|
| 01/13/2022 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Converted 616,786 shares
@ $0
Converted 616,786 convertible preferred
@ $0 |
|
| 10/27/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Converted 785,303 shares
@ $0
Bought 625,000 shares
@ $16, valued at
$10M
Converted 548,288 convertible preferred
@ $0
Converted 237,015 convertible preferred
@ $0 |
|
| 10/15/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Converted 668,854 shares
@ $0
Bought 450,000 shares
@ $16, valued at
$7.2M
Converted 668,854 convertible preferred
@ $0 |
|
| 09/21/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Converted 757,432 shares
@ $0
Bought 312,500 shares
@ $16, valued at
$5M
Converted 757,432 convertible preferred
@ $0 |
|
| 08/10/2021 |
4
| Chen Bihua (Director) has filed a Form 4 on Erasca, Inc.|
Txns:
| Sold 200,000 shares
@ $18.765, valued at
$3.8M
Bought 200,000 shares
@ $22.1, valued at
$4.4M
|
|
| 08/05/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Immuneering Corp|
Txns:
| Converted 1,702,628 shares
@ $0
Bought 550,000 shares
@ $15, valued at
$8.3M
Converted 1,702,628 convertible preferred
@ $0 |
|
| 08/04/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Converted 426,393 shares
@ $0
Converted 426,393 convertible preferred
@ $0 |
|
| 07/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Aerovate Therapeutics, Inc.|
Txns:
| Converted 1,530,691 shares
@ $0
Bought 500,000 shares
@ $14, valued at
$7M
Converted 1,530,691 convertible preferred
@ $0 |
|
| 07/01/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Elevation Oncology, Inc.|
Txns:
| Converted 1,983,168 shares
@ $0
Bought 250,000 shares
@ $16, valued at
$4M
Converted 1,983,168 convertible preferred
@ $0 |
|
| 06/30/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Converted 2,602,200 shares
@ $0
Bought 600,000 shares
@ $19, valued at
$11.4M
Converted 2,124,343 convertible preferred
@ $0
Converted 477,857 convertible preferred
@ $0 |
|
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Converted 4,364,844 shares
@ $0
Bought 750,000 shares
@ $20, valued at
$15M
Converted 2,959,891 convertible preferred
@ $0
Converted 1,404,953 convertible preferred
@ $0 |
|
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Converted 1,492,060 shares
@ $0
Bought 800,000 shares
@ $18, valued at
$14.4M
Converted 1,492,060 convertible preferred
@ $0 |
|
| 11/23/2020 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Converted 2,845,544 shares
@ $0
Bought 425,000 shares
@ $19, valued at
$8.1M
Converted 2,122,367 convertible preferred
@ $0
Converted 723,177 convertible preferred
@ $0 |
|
|
|
|